Dr. Salha Bujassoum, Senior Consultant, Hematology and Oncology, and Director of the Hereditary and High-Risk Screening Program at Hamad Medical Corporation (HMC), has announced that in 2017, 800 individuals (male and female) were referred to the Heredita
Read more →